V L Reichardt - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

V L Reichardt

Showing results (1-10 of 10) with videos related to

Pageof 1

Sort By:

Cytotherapy|February 27, 2004

DC-based immunotherapy of B-cell malignanciesV L Reichardt, Peter Brossart

Blood|October 26, 2000

Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cellsP Brossart, S Wirths, G Stuhler, et al.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 1, 1997

Rationale for adjuvant idiotypic vaccination after high-dose therapy for multiple myelomaV L Reichardt, C Y Okada, K E Stockerl-Goldstein, et al.

Blood|December 3, 1998

Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factorP Brossart, F Grünebach, G Stuhler, et al.

Cancer Research|September 2, 2000

Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cellsP Brossart, A Zobywalski, F Grünebach, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2009

A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignanciesA du Bois, J Huober, P Stopfer, et al.

Proceedings of the National Academy of Sciences of the United States of America|February 17, 1999

Immune regulatory loops determine productive interactions within human T lymphocyte-dendritic cell clustersG Stuhler, A Zobywalski, F Grünebach, et al.

Blood|June 11, 1999

Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapiesP Brossart, K S Heinrich, G Stuhler, et al.

Blood|March 26, 1999

Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma--a feasibility studyV L Reichardt, C Y Okada, A Liso, et al.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 1998

Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignanciesG D Long, M D Amylon, K E Stockerl-Goldstein, et al.

Pageof 1

Search research articles

Showing results (1-10 of 10) with videos related to

Sort By:

Pageof 1

Cytotherapy|February 27, 2004

DC-based immunotherapy of B-cell malignanciesV L Reichardt, Peter Brossart

Blood|October 26, 2000

Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cellsP Brossart, S Wirths, G Stuhler, et al.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 1, 1997

Rationale for adjuvant idiotypic vaccination after high-dose therapy for multiple myelomaV L Reichardt, C Y Okada, K E Stockerl-Goldstein, et al.

Blood|December 3, 1998

Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factorP Brossart, F Grünebach, G Stuhler, et al.

Cancer Research|September 2, 2000

Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cellsP Brossart, A Zobywalski, F Grünebach, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2009

A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignanciesA du Bois, J Huober, P Stopfer, et al.

Proceedings of the National Academy of Sciences of the United States of America|February 17, 1999

Immune regulatory loops determine productive interactions within human T lymphocyte-dendritic cell clustersG Stuhler, A Zobywalski, F Grünebach, et al.

Blood|June 11, 1999

Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapiesP Brossart, K S Heinrich, G Stuhler, et al.

Blood|March 26, 1999

Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma--a feasibility studyV L Reichardt, C Y Okada, A Liso, et al.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 1998

Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignanciesG D Long, M D Amylon, K E Stockerl-Goldstein, et al.

Pageof 1